Profiel
Gerald Hogue is the founder of OpTx Corp.
(founded in 1993) and Viviphi Ltd. (founded in 2015, title: Chairman, President & Chief Executive Officer).
Mr. Hogue is currently a Director at POINT Biopharma, Inc. (since 2020).
Formerly, Independent Director at POINT Biopharma Global, Inc. (2021-2023).
Actieve functies van Gerald Hogue
| Bedrijven | Functie | Begin |
|---|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer | Directeur/Bestuurslid | 01-12-2020 |
Eerdere bekende functies van Gerald Hogue
| Bedrijven | Functie | Einde |
|---|---|---|
| POIT BIOP | Directeur/Bestuurslid | 27-12-2023 |
Viviphi Ltd.
Viviphi Ltd. Packaged SoftwareTechnology Services Provides artificial intelligence informatics software platform for cancer care | Algemeen Directeur | 01-12-2023 |
OpTx Corp.
OpTx Corp. Packaged SoftwareTechnology Services Provides oncology-specific software and services providers | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
OpTx Corp.
OpTx Corp. Packaged SoftwareTechnology Services Provides oncology-specific software and services providers | Technology Services |
Viviphi Ltd.
Viviphi Ltd. Packaged SoftwareTechnology Services Provides artificial intelligence informatics software platform for cancer care | Technology Services |
POINT Biopharma Global, Inc.
POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer | Commercial Services |
















